Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Valicare GmbH now offers additional services along the entire product life cycle of pharmaceutically and biotechnologically produced drugs.
read more
Wednesday, September 16, 2020
Valneva and Dynavax announced a commercial partnership for the supply of Dynavax's CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001.
read more
Wednesday, September 13, 2017
Vanrx Pharmasystems is introducing the Microcell Vial Filler, a new gloveless robotic isolator for aseptic filling.
read more
Wednesday, December 07, 2022
Vantage Nutrition, an ACG Group company, announced on 5th December 2022 that it has acquired Philadelphia-based ‘AquaCap’ – an asset of Nestlé Health Science.
read more
Vectalys and FlashCell have merged to create Flash Therapeutics, a new privately held gene therapy company developing gene and cell therapeutics.
read more
Monday, February 10, 2020
Vectura Group announced Sharon Johnson has been appointed to the position of Executive Vice President for Delivery Management, a newly-created leadership role.
read more
Vectura Group announced Mark Bridgewater has been appointed as Chief Commercial Officer, a newly-created role focused in the Company.
read more
Friday, December 18, 2020
Vectura has announced its partner Hikma has launched its generic version of GlaxoSmithKline’s Advair Diskus, 100mcg/50mcg and 250mcg/50mcg doses, in the US.
read more
Monday, December 21, 2020
Vectura Group announced an expansion of its capabilities to handle and develop HPAPIs at its facility in Chippenham, U.K.
read more
Wednesday, December 09, 2020
Vectura has signed a global license and development agreement with Kinaset for VR588, a preclinical novel inhaled pan-JAK inhibitor for prevention and treatment of severe asthma.
read more
Wednesday, November 08, 2017
Velesco announced the award of a subcontract for analytical method development, manufacturing clinical supplies, and testing the stability of an investigational drug for the treatment for Beta-Thalassemia.
read more
Wednesday, September 04, 2019
Velesco Pharma will triple its clinical manufacturing capacity with the purchase and fit-out of a new, state-of-the-art facility in Wixom, Michigan.
read more
Venomtech is collaborating with Charles River Laboratories, International Inc. to help drug developers explore venom-derived compounds for a wide range of therapeutic targets.
read more
Veristat, a global clinical research organization (CRO), announced the expansion and strengthening of its service capabilities by acquiring SFL (Solutions for Life Sciences). With headquarters in Basel, Switzerland and several European affiliates, ...
read more
Thursday, January 05, 2023
Verrica Pharmaceuticals Inc. announced the successful completion of the technology transfer of bulk solution manufacturing to Piramal Pharma Solutions.
read more